Oral Ethanol Treatment for Ethylene Glycol Intoxication.

ethylene glycol ethylene glycol intoxication oral ethanol treatment throat pain

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
25 Dec 2020
Historique:
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 30 1 2021
Statut: epublish

Résumé

Ethylene glycol is an odorless, sweet-tasting liquid found in industrial solutions such as antifreeze and windshield wiper fluid. Brake fluid, an automobile transmission liquid, contains poisonous alcohols such as glycol ethers and ethylene glycols. The toxicity of ethylene glycol is associated with toxic metabolite production by the liver enzyme alcohol dehydrogenase. Administration of either intravenous ethanol or fomepizole, both of which competitively inhibit ethylene glycol metabolism by alcohol dehydrogenase and can prevent the production and accumulation of the toxic metabolites, can be used as an antidote. A 42-year-old male car mechanic was transferred to our hospital after accidentally ingesting approximately 100 mL of brake fluid. Immediately after ingestion, he threw up most of the ingested liquid; however, he complained of nausea and throat pain and was moved to our emergency department. The patient was successfully treated with administration of oral ethanol in the form of whisky through a nasogastric tube since neither intravenous ethanol nor fomepizole was available in our hospital at the time of his presentation. Our case demonstrates that oral ethanol can be used as an alternative treatment for patients with ethylene glycol intoxication.

Identifiants

pubmed: 33510981
doi: 10.7759/cureus.12268
pmc: PMC7827791
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e12268

Informations de copyright

Copyright © 2020, Sasanami et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Iran J Kidney Dis. 2016 Nov;10(6):344-350
pubmed: 27903992
Clin J Am Soc Nephrol. 2008 Jan;3(1):208-25
pubmed: 18045860
Crit Care Clin. 2012 Oct;28(4):661-711
pubmed: 22998995
Rom J Morphol Embryol. 2018;59(3):965-969
pubmed: 30534841
Am J Med Sci. 2010 Mar;339(3):276-81
pubmed: 20090509
J Med Case Rep. 2019 Jul 3;13(1):203
pubmed: 31266532
Am J Hosp Pharm. 1981 Jul;38(7):1024-7
pubmed: 7258202
J Toxicol Clin Toxicol. 1999;37(5):537-60
pubmed: 10497633
Br J Clin Pharmacol. 2016 Mar;81(3):505-15
pubmed: 26551875
Case Rep Crit Care. 2016;2016:9157393
pubmed: 27847651
Neth J Med. 2014 Feb;72(2):73-9
pubmed: 24659589
Anaesthesia. 1994 Nov;49(11):964-7
pubmed: 7802243
Clin Toxicol (Phila). 2011 Jul;49(6):478-84
pubmed: 21824058
Clin Liver Dis. 2012 Nov;16(4):667-85
pubmed: 23101976
CJEM. 2002 Jan;4(1):34-40
pubmed: 17637146

Auteurs

Misa Sasanami (M)

Center for Graduate Medical Education, Okayama University Hospital, Okayama, JPN.

Taihei Yamada (T)

Department of Emergency, Critical Care and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JPN.

Takafumi Obara (T)

Department of Emergency, Critical Care and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JPN.

Atsunori Nakao (A)

Department of Emergency, Critical Care and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JPN.

Hiromichi Naito (H)

Department of Emergency, Critical Care and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JPN.

Classifications MeSH